[Use of cryopreserved bone marrow in oncological patients with depressed hematopoiesis].
The effectiveness of allomyelotransplantation has been assessed in 97 oncological patients with different localization of the tumor process. The data indicate that myelotherapy is a valuable adjunct in treatment of depressed hemopoiesis in oncological patients, which allowed the course of radio and chemotherapy to be continued in most of them.